Association between tobacco & nicotine product use and allergic rhinitis: a cross-sectional study. Download PDF Abstract Allergic rhinitis (AR) affects over 1.4 billion individuals globally and remains one of the most burdensome chronic inflammatory conditions of the upper airway. Whether tobacco and nicotine product use—including combustible products (cigarettes and hookah) and the rapidly growing use of electronic cigarettes (ECs)—contributes meaningfully to AR risk is still contested.
This study set out to examine whether current tobacco/nicotine product use, and the type of product used, is associated with AR in a mixed Jordanian and international sample. We conducted a cross-sectional study using a self-administered structured questionnaire. Using an online convenience sample, 500 individuals aged 18–50 years were invited and 385 completed responses were analyzed.
AR was identified using the Score for Allergic Rhinitis (SFAR), a validated 12-item tool; a score of ≥ 7 out of 16 was considered diagnostic. Current tobacco/nicotine product users ( n = 137; 35.6%) were compared against non-users ( n = 248; 64.4%) and further categorized by primary product—conventional cigarettes or hookah (combustible) and e-cigarettes (non-combustible). Chi-square tests and multivariable binary logistic regression adjusting for age, gender, education, income, and region examined associations between product use and AR status.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with qualified healthcare professionals for medical decisions and treatment options.
Discover more from ChuckysCarnage
Subscribe to get the latest posts sent to your email.
